Replies to post #9637 on Oncology Pharma Inc (ONPH)

[threewheeler]

Trading symbol: ONPH
Exact title and class of securities outstanding: common
CUSIP: 836171 20 7
Par or stated value: $0.001
Total shares authorized: 900,000,000 as of date: August 11, 2020
Total shares outstanding: 155,146,092 as of date: August 11, 2020
Number of shares in the Public Float: 19,927,822 as of date: August 11, 2020
Total number of shareholders of record: 201 as of date: August 11, 2020

[threewheeler]

7) Officers, Directors, and Control Persons
Name of
Officer/Director
or Control Person
Affiliation with
Company (e.g.
Officer/Director/Owner
of more than 5%)
Residential Address
(City / State Only)
Number of
shares owned
Share
type/class
Ownership
Percentage
of Class
Outstanding
Note
Charles Wagner Chairman/Director
San Francisco CA
60,000,764 Common 38.6% Restricted
George Malasek Chief Executive Officer Carlsbad CA 1,500,020 Common .97% Restricted
Carlos Barnett Director
Carlsbad CA
10,250,000
1
Common
Preferred
6.66%
100%
Restricted
Shawn Crouse Director Corte Madera CA 10,350,000 Common 6.67% Restricted
Vijay Mahant Chief Scientific Officer San Diego CA 5,100,000 Common 3.28% Restricted
Stefan Gruenwald, Director Encinitas CA 8,600,000 Common 5.5% Restricted

[threewheeler]

100/1 r/s on such a tiny float already dam ONPH